JYNARQUE® (tolvaptan) 15, 30, 45, 60, 90mg tablets

Please see IMPORTANT SAFETY INFORMATION and FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE.
 
JYNARQUE is proven to slow kidney function decline in adults at risk for rapidly progressing ADPKD.
 
JYNARQUE can cause serious liver problems that can lead to the need for liver transplant or can lead to death.
 
These videos are meant to be a resource to help you learn more about JYNARQUE. We encourage you to watch and share with others. This content is for informational purposes only and is not intended as a replacement for discussions with your doctor.

This page is not intended for the reporting of side effects associated with the use of JYNARQUE. 

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at 1‑800‑438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

This content is intended for US consumers only. 

© 2024 Otsuka America Pharmaceutical, Inc. All rights reserved. 

April 2024 10US24EBC0012